Use of Early Inhaled Nitric Oxide Therapy in Fat Embolism Syndrome to Prevent Right Heart Failure

<table>Changes in PO<sub>2</sub>/FiO<sub>2</sub> ratio during the second patient’s ICU stay. Inhaled NO therapy was initiated on the third day of the patient’s hospitalization (represented by the first black arrow) due to severe unresponsive persistent hypoxemia (PO<sub>2</sub>/FiO<sub>2</sub>-120). By the sixth day after hospitalization, the PaO<sub>2</sub>/FiO<sub>2</sub> ratio was improving and inhaled NO therapy was discontinued (represented by the second black arrow).</table>

Case Reports in Critical Care

fig2

Figure 2

Figure 2: Use of Early Inhaled Nitric Oxide Therapy in Fat Embolism Syndrome to Prevent Right Heart Failure 